The TFOS DEWS II is nearing completion! The Harmonization Committee, which is composed of Jennifer Craig, Lyndon Jones, Daniel Nelson, Fiona Stapleton, David Sullivan, Mark Willcox and James Wolffsohn, will meet in early January in Sydney, Australia, to finalize all the Subcommittee reports. These include Definition & classification; Sex, hormones & gender; Epidemiology; Pathophysiology; Iatrogenic; Tear film; Pain & sensation; Diagnosis; Management & Therapy; and Clinical trial design. TFOS anticipates that this evidence-based DEWS II report will be published in The Ocular Surface in Spring 2017.
More than 150 clinical and basic science experts from around the world have created this report. We express our sincere appreciation to all of you, as well as to the companies that have donated the funds to make this initiative possible: Title Sponsor: Alcon, Platinum Sponsor: Shire, Gold Sponsor: Allergan, Silver Sponsor: Bausch & Lomb, Bronze Sponsors: Akorn, CooperVision, Dompé, Horus, Lubris, Oculeve, TearLab, THEA, SIFI, Johnson & Johnson Vision Care, Sponsors: Quint Health, Scope Ophthalmics and Senju.
For more information, please visit the TFOS DEWS II website: http://tfosdewsreport.org/